Study Stopped
Closed due to continued slow enrollment.
Spinal Cord Stimulation With Precision® System Versus Reoperation for Failed Back Surgery Syndrome
Evidence
1 other identifier
interventional
28
4 countries
18
Brief Summary
The EVIDENCE trial is a randomized controlled trial comparing the therapeutic effectiveness and cost-effectiveness of the Precision® Spinal Cord Stimulation with that of reoperation as a treatment of pain in patients with Failed Back Surgery Syndrome (FBSS). FBSS is defined as persistent or recurrent pain following one or more lumbosacral spine surgical procedures. Surgical procedures that can result in FBSS can be categorized as either decompression or decompression followed by fusion with or without instrumentation. The pain of FBSS is categorized as neuropathic, which involves pathological nerve activity and is commonly characterized by patients as shooting or burning and/or nociceptive, which signals actual or impending tissue damage or inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Feb 2010
Typical duration for phase_4
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2009
CompletedFirst Posted
Study publicly available on registry
December 21, 2009
CompletedStudy Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedResults Posted
Study results publicly available
October 28, 2013
CompletedNovember 16, 2020
November 1, 2020
3.2 years
December 17, 2009
June 4, 2013
November 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of Subjects Showing ≥50% Self-reported Leg Pain Relief From Baseline Without Request for Crossover to the Other Treatment
3, 6- and 12- months post-index procedure
Study Arms (2)
Precision Spinal Cord Stimulator
EXPERIMENTALSpinal Cord Stimulation
Back Surgery
ACTIVE COMPARATORDiscectomy, laminotomy, laminectomy, foraminotomy, fusion with or without instrumentation
Interventions
Programming settings will be specific to the individual needs in accordance with the labeling
Different types of back surgery may be performed
Eligibility Criteria
You may qualify if:
- Primary pain type - neuropathic with concordant radicular or neurological findings
- Significant complaint of persistent or recurrent radicular leg pain, with or without low back pain
- One or more prior lumbosacral surgical procedures (no upper limit)
- At least 6 months duration of persistent or recurrent radicular leg pain, with or without low back pain
- Study candidates meet the criteria for a specific surgical intervention as recorded by a surgeon: pain refractory to conservative care, with concordant neurologic, tension, and/or mechanical signs and imaging findings of surgically remediable neural compression
- MRI or CT myelogram of the lumbar and thoracic spine (within 12 months prior to screening) that rules out pathology that might compromise SCS electrode placement or pathology, in addition to neural compression, that might contribute to the subject's pain
- All study candidates must pass study site's routine psychological/psychiatric evaluation for SCS before randomization to SCS or reoperation
- At least 18 years of age
- Subject signs informed consent
You may not qualify if:
- Chief complaint of mechanical low back pain (e.g. pain that a recumbent position relieves completely)
- Pain intensity of always 10 on a 0-10 Numerical Rating Scale over the past 6 months based on subject recall
- Radiographic evidence of frank instability (grossly mobile spondylolisthesis or abnormal subluxation) requiring fusion, calcific arachnoiditis, or severe thoracic stenosis
- Radiographically demonstrated (by myelographic block or its MRI equivalent) critical cauda equinal compression
- A disabling or potentially disabling neurologic deficit (e.g., foot drop, neurogenic bladder) in the distribution of a nerve root or roots caused by surgically remediable compression
- A predominance of non-organic signs on physical exam
- A concurrent clinically significant or disabling chronic pain problem or condition that is likely to confound evaluation of study endpoints (e.g., chronic migraine, significant arthrosis of the hip associated with groin pain as primary complaint)
- Significant substance abuse issues
- Major untreated psychiatric comorbidity
- Unresolved issues of secondary gain (e.g., litigation)
- Expected inability to report treatment outcome adequately
- Expected inability to operate SCS system
- Pregnancy (actual or planned)
- Life expectancy less than 3 years due to other serious medical condition(s)
- Active local or systemic infection
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (18)
Scripps Clinic
La Jolla, California, 92037, United States
University of California San Diego
La Jolla, California, 92037, United States
Orthopedic Research Foundation
Savannah, Georgia, 31405, United States
Millenium Pain Center
Bloomington, Illinois, 61701, United States
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
The University of Illinois Medical Center
Chicago, Illinois, 60612, United States
Sinai Hospital of Baltimore
Baltimore, Maryland, 21209, United States
St. Patrick Hospital
Missoula, Montana, 59802, United States
The Center for Clinical Research, LLC
Winston-Salem, North Carolina, 27103, United States
Geisinger Medical Center
Danville, Pennsylvania, 17822, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Swedish Neuroscience Institute
Seattle, Washington, 98122, United States
Pacific Medical Center
Seattle, Washington, 98144, United States
Hopital de Enfant-Jesus
Québec, Quebec, G1J 1Z4, Canada
Regina General Hospital
Regina, Saskatchewan, S4P 0W5, Canada
CHU de Nantes-Hopital Laennec
Nantes, 44093, France
Frenchay Hospital
Bristol, BS16 1LE, United Kingdom
James Cook University Hospital
Middlesbrough, TS4 3BW, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
This study was terminated early due to slow enrollment. Only 28 of the 200 planned subjects were enrolled. Based on the small numbers and early termination, the primary outcome measures were not analyzed.
Results Point of Contact
- Title
- Valerie Lucero-Cimmarusti
- Organization
- Boston Scientific
Study Officials
- PRINCIPAL INVESTIGATOR
Richard North, M.D.
The Sandra and Malcolm Berman Brain & Spine Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2009
First Posted
December 21, 2009
Study Start
February 1, 2010
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
November 16, 2020
Results First Posted
October 28, 2013
Record last verified: 2020-11